Evaluation of Trabecular Structure Using Fractal Analysis in Patients Taking Proton Pump Inhibitors

Year 2022, Volume: 23 Issue: 3, 303 - 309, 30.09.2022

Şelale Özel , Özlem Okumuş , Zeliha Zuhal Yurdabakan

Abstract

Objective: The aim of this study was to evaluate the changes in the trabecular bone structure in patients using proton pump inhibitors (PPI) by performing measurements with fractal analysis, mandibular cortical width (MCW) and panoramic mandibular index (PMI) on panoramic radiographs.
Materials and Methods: This study consists of 46 patients (20 males and 26 females) using PPI drugs regularly for at least 1 year and systemically healthy 46 persons (20 males, 26 females) as the control group. Fractal analysis was performed in five regions: the mandibular angle (ROI1), posterior mandible (ROI2), interdental area between apical of the second premolar and the first molar (ROI3), maxillary tuber region (ROI4), anterior mandible (ROI5). PMI and MCW as an indicative of osteoporosis, were measured on the panoramic radiographs.
Results: For re-evaluated measurements, interobserver and intraobserver agreements were found to be 0.985 and 0.987, respectively. ROI2-4 (1.732, 1.334, 1.333; respectively) were significantly lower in PPI users, whereas, there was no significant in ROI1 (1.605) and ROI5 (1.694). The values MCW and PMI were not statistically significant in PPI users.
Conclusion: Posterior region of the mandible, maxillary tuberosity and interdental region had lower trabecular microstructures in PPI users. The results of this study show that patients using PPI at least one year should be considered as regarding osteoporotic changes during dental treatment.

Keywords

Osteoporosis , proton pump inhibitors , fractal analysis , radiography , panoramic

References

• 1. Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 963-78.
• 2. Freedberg DE, Haynes K, Denburg MR, Zemel BS, Leonard MB, Abrams JA, et al. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study. Osteoporos Int 2015; 26: 2501-7.
• 3. US Food and Drug Administration FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs). 2011 Silver Spring, MD, US Food and Drug Administration.
• 4. Al Subaie A, Emami E, Tamimi I, Laurenti M, Eimar H, Abdallah MN, et al. Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an in vivo study on rat tibiae. J Clin Periodontol 2016; 43: 193-203.
• 5. Wu X, Al-Abedalla K, Abi-Nader S, Daniel NG, Nicolau B, Tamimi F. Proton pump inhibitors and the risk of osseointegrated dental implant failure: a cohort study. Clin Implant Dent Relat Res 2017; 19: 222-32.
• 6. Altay MA, Sindel A, Özalp Ö, Yıldırımyan N, Kocabalkan B. Proton pump inhibitor intake negatively affects the osseointegration of dental implants: a retrospective study. J Korean Assoc Oral Maxillofac Surg 2019; 45: 135-40.
• 7. White SC, Rudolph D. Alterations of the trabecular pattern of the jaws in patients with osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 628-35.
• 8. Benson BW, Prihoda TJ, Glass BJ. Variations in adult cortical bone mass as measured by a panoramic mandibular index. Oral Surg Oral Med Oral Pathol 1991; 71: 349-56.
• 9. Goltzman D, Mannstadt M, Marcocci C. Physiology of the Calcium-Parathyroid Hormone-Vitamin D. Front Horm Res 2018; 50: 1-13.
• 10. Hyun JJ, Chun HJ, Keum B, Seo YS, Kim YS, Jeen YT, et al. Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts. Int J Mol Med 2010; 26: 877-83.
• 11. Costa‐Rodrigues J, Reis S, Teixeira S, Lopes S, Fernandes MH. Dose‐dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity. FEBS J 2013; 280: 5052-64.
• 12. Abrahamsen B, Pia E, Eastell R. Proton pump inhibitor use and the antifracture efficacy of alendronate. Arch Intern Med 2011; 171: 998-1004.
• 13. Roux C, Goldstein JL, Zhou X, Klemes A, Lindsay R. Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors. Osteoporos Int 2012; 23: 277-84.
• 14. Göller Bulut D, Bayrak S, Uyeturk U, Ankaralı H. Mandibular indexes and fractal properties on the panoramic radiographs of the patients using aromatase inhibitors. Br J Radiol 2018; 91: 20180442.
• 15. Southard KA, Southard TE. Comparison of digitized radiographic alveolar features between 20- and 70-year-old women: a preliminary study. Oral Surg Oral Med Oral Pathol 1992; 74: 111-7.
• 16. Lang P, Steiger P, Faulkner K, Gluer C, Genant HK. Osteoporosis: current techniques and recent developments in quantitative bone densitometry. Radiol Clin North Am 1991; 29: 49-76.
• 17. Caligiuri P, Giger ML, Favus M. Multifractal radiographic analysis of osteoporosis. Med Phys 1994; 21: 503-8.
• 18. Bayrak S, Göller Bulut D, Orhan K, Sinanoğlu EA, Kurşun Çakmak EŞ, Mısırlı M, et al. Evaluation of osseous changes in dental panoramic radiography of thalassemia patients using mandibular indexes and fractal size analysis. Oral Radiol 2020; 36: 18-24.
• 19. Demiralp KÖ, Kurşun-Çakmak EŞ, Bayrak S, Akbulut N, Atakan C, Orhan K. Trabecular structure designation using fractal analysis technique on panoramic radiographs of patients with bisphosphonate intake: a preliminary study. Oral Radiol 2019; 35: 23-8.
• 20. Gulec M, Tassoker M, Ozcan S, Orhan K. Evaluation of the mandibular trabecular bone in patients with bruxism using fractal analysis. Oral Radiol 2021; 37: 36-45.
• 21. Pauwels R, Faruangsaeng T, Charoenkarn T, Ngonphloy N, Panmekiate S. Effect of exposure parameters and voxel size on bone structure analysis in CBCT. Dentomaxillofac Radiol 2015; 44: 20150078.
• 22. Magat G, Ozcan Sener S. Evaluation of trabecular pattern of mandible using fractal dimension, bone area fraction, and gray scale value: comparison of cone-beam computed tomography and panoramic radiography. Oral Radiol 2019; 35: 35-42.